• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae.OmpK26,一种与肺炎克雷伯菌碳青霉烯类耐药相关的新型孔蛋白。
Antimicrob Agents Chemother. 2011 Oct;55(10):4742-7. doi: 10.1128/AAC.00309-11. Epub 2011 Aug 1.
2
Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.全球趋势在蛋白质组重塑的外膜调节抗菌通透性在肺炎克雷伯菌。
mBio. 2020 Apr 14;11(2):e00603-20. doi: 10.1128/mBio.00603-20.
3
Role of association of OmpK35 and OmpK36 alteration and bla and/or bla genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae.OmpK35 和 OmpK36 改变与 bla 和/或 bla 基因的关联在非碳青霉烯酶产生肺炎克雷伯菌中赋予碳青霉烯类耐药的作用。
Int J Antimicrob Agents. 2018 Dec;52(6):898-905. doi: 10.1016/j.ijantimicag.2018.03.020. Epub 2018 Apr 2.
4
Role of Klebsiella pneumoniae LamB Porin in antimicrobial resistance.肺炎克雷伯菌 LamB 孔蛋白在抗菌药物耐药性中的作用。
Antimicrob Agents Chemother. 2011 Apr;55(4):1803-5. doi: 10.1128/AAC.01441-10. Epub 2011 Jan 31.
5
Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.肺炎克雷伯菌临床分离株对碳青霉烯类药物敏感性降低,与质粒介导的β-内酰胺酶产生及外膜孔蛋白OmpK36缺失有关。
J Med Microbiol. 2009 Sep;58(Pt 9):1196-1202. doi: 10.1099/jmm.0.008094-0. Epub 2009 Jun 15.
6
High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.肺炎克雷伯菌临床分离株中的高水平碳青霉烯耐药性是由bla(ACT-1)β-内酰胺酶产生、孔蛋白OmpK35/36插入失活以及磷酸盐转运孔蛋白phoe的下调共同导致的。
Antimicrob Agents Chemother. 2006 Oct;50(10):3396-406. doi: 10.1128/AAC.00285-06.
7
Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.产碳青霉烯酶肺炎克雷伯菌(KPC)中孔蛋白表达的特征可鉴定对黏菌素和碳青霉烯类药物联合治疗最敏感的分离株。
Antimicrob Agents Chemother. 2013 May;57(5):2147-53. doi: 10.1128/AAC.02411-12. Epub 2013 Mar 4.
8
Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.产碳青霉烯酶肺炎克雷伯菌与孔蛋白 OmpK36 缺失和 DHA-1 型β-内酰胺酶产生相关,表现出对碳青霉烯类和头孢西丁的耐药性。
Braz J Microbiol. 2013 Oct 30;44(2):435-42. doi: 10.1590/S1517-83822013000200015. eCollection 2013.
9
Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.对缺乏碳青霉烯酶的厄他培南不敏感肺炎克雷伯菌主要孔蛋白的全球调查。
J Med Microbiol. 2018 Mar;67(3):289-295. doi: 10.1099/jmm.0.000691. Epub 2018 Feb 5.
10
Reduced Susceptibility to Carbapenems in a Klebsiella pneumoniae Clinical Isolate Producing SCO-1 and CTX-M-15 β-Lactamases Together with OmpK35 and OmpK36 Porin Deficiency.一株同时产SCO-1和CTX-M-15β-内酰胺酶并伴有外膜孔蛋白OmpK35和OmpK36缺失的肺炎克雷伯菌临床分离株对碳青霉烯类药物敏感性降低
Antimicrob Agents Chemother. 2020 Jul 22;64(8). doi: 10.1128/AAC.00556-20.

引用本文的文献

1
Molecular characterization and resistance mechanisms of ertapenem-non-susceptible carbapenem-resistant co-harboring ESBLs or AmpC enzymes with porin loss or efflux pump overexpression.产超广谱β-内酰胺酶(ESBLs)或AmpC酶且伴有孔蛋白缺失或外排泵过表达的耐厄他培南碳青霉烯耐药菌的分子特征及耐药机制
J Bacteriol. 2025 Jul 24;207(7):e0014825. doi: 10.1128/jb.00148-25. Epub 2025 Jun 13.
2
Interplay between porin deficiency, fitness, and virulence in carbapenem-non-susceptible Pseudomonas aeruginosa and Enterobacteriaceae.碳青霉烯不敏感的铜绿假单胞菌和肠杆菌科细菌中孔蛋白缺乏、适应性与毒力之间的相互作用
PLoS Pathog. 2025 Feb 7;21(2):e1012902. doi: 10.1371/journal.ppat.1012902. eCollection 2025 Feb.
3
Porin expression in clinical isolates of Klebsiella pneumoniae: a comparison of SDS-PAGE and MALDI-TOF/MS and limitations of whole genome sequencing analysis.肺炎克雷伯菌临床分离株的孔蛋白表达:SDS-PAGE 和 MALDI-TOF/MS 的比较及全基因组测序分析的局限性。
Ann Clin Microbiol Antimicrob. 2024 Nov 24;23(1):103. doi: 10.1186/s12941-024-00761-9.
4
TolC contributes to antimicrobial resistance, exopolysaccharide production, and virulence.托尔克(TolC)有助于抗菌药物耐药性、胞外多糖产生和毒力。
Infect Immun. 2023 Dec 12;91(12):e0030323. doi: 10.1128/iai.00303-23. Epub 2023 Nov 20.
5
Occurrence and Characteristics of Carbapenem-Resistant Strains Isolated from Hospitalized Patients in Poland-A Single Centre Study.波兰一家单中心研究:从住院患者中分离出的耐碳青霉烯类菌株的发生情况及特征
Pathogens. 2022 Jul 29;11(8):859. doi: 10.3390/pathogens11080859.
6
Extensively Drug-Resistant Klebsiella pneumoniae Counteracts Fitness and Virulence Costs That Accompanied Ceftazidime-Avibactam Resistance Acquisition.广泛耐药肺炎克雷伯菌抵消了头孢他啶-阿维巴坦耐药获得伴随的适应性和毒力代价。
Microbiol Spectr. 2022 Jun 29;10(3):e0014822. doi: 10.1128/spectrum.00148-22. Epub 2022 Apr 18.
7
Reduced Virulence and Enhanced Host Adaption during Antibiotics Therapy: a Story of a Within-Host Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 Evolution in a Patient with a Serious Scrotal Abscess.抗生素治疗期间毒力降低和宿主适应性增强:一名严重阴囊脓肿患者体内碳青霉烯类耐药肺炎克雷伯菌 11 型序列的故事
mSystems. 2022 Apr 26;7(2):e0134221. doi: 10.1128/msystems.01342-21. Epub 2022 Mar 1.
8
In vitro activity of carvacrol in combination with meropenem against carbapenem-resistant Klebsiella pneumoniae.体外研究香芹酚与美罗培南联合应用对耐碳青霉烯类肺炎克雷伯菌的活性。
Folia Microbiol (Praha). 2022 Feb;67(1):143-156. doi: 10.1007/s12223-021-00908-7. Epub 2021 Nov 2.
9
Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri.产 KPC-2 型碳青霉烯酶的肺炎克雷伯菌临床分离株中,一种对头孢他啶-阿维巴坦耐药的 KPC-82 型碳青霉烯酶的特性研究。
Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0015021. doi: 10.1128/AAC.00150-21.
10
An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Strain HUMC1.对广泛耐药(XDR)菌株HUMC1中BfmR调控的抗菌药物耐药性的评估
Front Microbiol. 2020 Oct 29;11:595798. doi: 10.3389/fmicb.2020.595798. eCollection 2020.

本文引用的文献

1
Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence.肺炎克雷伯菌外膜孔蛋白 OmpK35 和 OmpK36 既参与抗菌药物耐药性的形成,也与毒力有关。
Antimicrob Agents Chemother. 2011 Apr;55(4):1485-93. doi: 10.1128/AAC.01275-10. Epub 2011 Jan 31.
2
Role of Klebsiella pneumoniae LamB Porin in antimicrobial resistance.肺炎克雷伯菌 LamB 孔蛋白在抗菌药物耐药性中的作用。
Antimicrob Agents Chemother. 2011 Apr;55(4):1803-5. doi: 10.1128/AAC.01441-10. Epub 2011 Jan 31.
3
Carbapenem Heteroresistance in VIM-1-producing Klebsiella pneumoniae isolates belonging to the same clone: consequences for routine susceptibility testing.产 VIM-1 肺炎克雷伯菌同克隆株碳青霉烯类药物异质性耐药:对常规药敏试验的影响。
J Clin Microbiol. 2010 Nov;48(11):4089-93. doi: 10.1128/JCM.01130-10. Epub 2010 Sep 15.
4
Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model.膜外排和内流调节了秀丽隐杆线虫模型中肺炎克雷伯菌的多药耐药性和毒力。
Antimicrob Agents Chemother. 2010 Oct;54(10):4373-8. doi: 10.1128/AAC.01607-09. Epub 2010 Aug 2.
5
Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae.与产 KPC 肺炎克雷伯菌碳青霉烯类耐药升高相关的遗传因素。
Antimicrob Agents Chemother. 2010 Oct;54(10):4201-7. doi: 10.1128/AAC.00008-10. Epub 2010 Jul 26.
6
Analysis of Candida albicans plasma membrane proteome.白色念珠菌质膜蛋白质组分析。
Proteomics. 2009 Oct;9(20):4770-86. doi: 10.1002/pmic.200800988.
7
NanC crystal structure, a model for outer-membrane channels of the acidic sugar-specific KdgM porin family.NanC晶体结构,酸性糖特异性KdgM孔蛋白家族外膜通道的模型。
J Mol Biol. 2009 Dec 11;394(4):718-31. doi: 10.1016/j.jmb.2009.09.054. Epub 2009 Sep 29.
8
In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment.在美罗培南治疗过程中 OmpK36 丢失导致耐碳青霉烯类肺炎克雷伯菌的体内选择。
Diagn Microbiol Infect Dis. 2009 Dec;65(4):447-9. doi: 10.1016/j.diagmicrobio.2009.08.010. Epub 2009 Sep 18.
9
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.外膜孔蛋白K36对产KPC肺炎克雷伯菌碳青霉烯类药物敏感性的影响
J Med Microbiol. 2009 Oct;58(Pt 10):1303-1308. doi: 10.1099/jmm.0.012575-0. Epub 2009 Jun 25.
10
Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.肺炎克雷伯菌临床分离株对碳青霉烯类药物敏感性降低,与质粒介导的β-内酰胺酶产生及外膜孔蛋白OmpK36缺失有关。
J Med Microbiol. 2009 Sep;58(Pt 9):1196-1202. doi: 10.1099/jmm.0.008094-0. Epub 2009 Jun 15.

OmpK26,一种与肺炎克雷伯菌碳青霉烯类耐药相关的新型孔蛋白。

OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae.

机构信息

Instituto Universitario de Investigaciones en Ciencias de la Salud, Universidad de las Islas Baleares, Palma de Mallorca, Spain.

出版信息

Antimicrob Agents Chemother. 2011 Oct;55(10):4742-7. doi: 10.1128/AAC.00309-11. Epub 2011 Aug 1.

DOI:10.1128/AAC.00309-11
PMID:21807980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3186958/
Abstract

Clinical isolates of Klebsiella pneumoniae resistant to carbapenems are being isolated with increasing frequency. Loss of the expression of the major nonspecific porins OmpK35/36 is a frequent feature in these isolates. In this study, we looked for porins that could compensate for the loss of the major porins in carbapenem-resistant organisms. Comparison of the outer membrane proteins from two K. pneumoniae clinical isogenic isolates that are susceptible (KpCS-1) and resistant (KpCR-1) to carbapenems revealed the absence of OmpK35/36 and the presence of a new 26-kDa protein in the resistant isolate. An identical result was obtained when another pair of isogenic isolates that are homoresistant (Kpn-3) and heteroresistant (Kpn-17) to carbapenems were compared. Mass spectrometry and DNA sequencing analysis demonstrated that this new protein, designated OmpK26, is a small monomeric oligogalacturonate-specific porin that belongs to the KdgM family of porins. Insertion-duplication mutagenesis of the OmpK26 coding gene, yjhA, in the carbapenem-resistant, porin-deficient isolate KpCR-1 caused the expression of OmpK36 and the reversion to the carbapenem-susceptible phenotype, suggesting that OmpK26 is indispensable for KpCR-1 to lose OmpK36 and become resistant to these antibiotics. Moreover, loss of the major porin and expression of OmpK26 reduced in vitro fitness and attenuated virulence in a murine model of acute systemic infection. Altogether, these results indicate that expression of the oligogalacturonate-specific porin OmpK26 compensates for the absence of OmpK35/36 and allows carbapenem resistance in K. pneumoniae but cannot restore the fitness of the microorganism.

摘要

临床分离的耐碳青霉烯类肺炎克雷伯菌的发生率正在不断增加。这些分离株的一个常见特征是主要非特异性孔蛋白 OmpK35/36 的表达缺失。在本研究中,我们寻找可以补偿耐碳青霉烯类药物的生物体中主要孔蛋白缺失的孔蛋白。比较对碳青霉烯类药物敏感(KpCS-1)和耐药(KpCR-1)的两种肺炎克雷伯菌临床同源分离株的外膜蛋白,发现耐药分离株中缺乏 OmpK35/36,存在一种新的 26kDa 蛋白。当比较另一对同源耐药(Kpn-3)和异源耐药(Kpn-17)的碳青霉烯类药物的同源分离株时,得到了相同的结果。质谱和 DNA 测序分析表明,这种新的蛋白,命名为 OmpK26,是一种小的单体寡半乳糖醛酸盐特异性孔蛋白,属于 KdgM 家族的孔蛋白。在耐碳青霉烯类药物、缺乏孔蛋白的 KpCR-1 分离株中,OmpK26 编码基因 yjhA 的插入-缺失突变导致 OmpK36 的表达和对碳青霉烯类药物的敏感性表型的恢复,表明 OmpK26 对于 KpCR-1 缺失 OmpK36 并对这些抗生素产生耐药性是不可或缺的。此外,主要孔蛋白的缺失和 OmpK26 的表达降低了体外适应性,并减弱了急性全身感染小鼠模型中的毒力。总之,这些结果表明,寡半乳糖醛酸盐特异性孔蛋白 OmpK26 的表达可以补偿 OmpK35/36 的缺失,使肺炎克雷伯菌对碳青霉烯类药物产生耐药性,但不能恢复微生物的适应性。